Redhill Biopharma
RDHL
₹128.88
Share price
-9.20%
Change (1 day)
-84.34%
Change (1 year)
Categories
Redhill Biopharma (RDHL) - Net assets
Net assets on the balance sheet as of December 2024 : -₹0.41 Billion
According to Redhill Biopharma's latest financial reports the company has -₹0.41 Billion in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Redhill Biopharma - Net assets on balance sheet (from 2011 to 2024)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $₹0.17 B | -104.3% |
| 2022-12-31 | $-₹4.01 Billion | -706.3% |
| 2021-12-31 | $₹0.66 B | -34.85% |
| 2020-12-31 | $₹1.01 B | -76.3% |
| 2019-12-31 | $₹4.27 B | 19.55% |
| 2018-12-31 | $₹3.57 B | 24.38% |
| 2017-12-31 | $₹2.87 B | -32.47% |
| 2016-12-31 | $₹4.26 B | 6.72% |
| 2015-12-31 | $₹3.99 B | 151.86% |
| 2014-12-31 | $₹1.58 B | 115.16% |
| 2013-12-31 | $₹0.73 B | -29.25% |
| 2012-12-31 | $₹1.04 B | 4.78% |
| 2011-12-31 | $₹0.99 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Sanofi SNY | ₹7.010 T | -1,719,339.80% | 🇫🇷 France |
 Merck MRK | ₹4.214 T | -1,033,625.52% | 🇺🇸 USA |
 GlaxoSmithKline GSK | ₹1.536 T | -376,828.59% | 🇬🇧 UK |
 Taro Pharmaceutical TARO | ₹154.92 B | -38,090.39% | 🇮🇱 Israel |
 Teva Pharmaceutical Industries TEVA | ₹545.90 B | -133,967.18% | 🇮🇱 Israel |